检索结果 - Lan Deng

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Failure of rewarding and locomotor stimulant doses of morphine to promote adult rat 50-kHz ultrasonic vocalizations

    Failure of rewarding and locomotor stimulant doses of morphine to promote adult rat 50-kHz ultrasonic vocalizations 由 Jennifer M. Wright, Lan Deng, Paul B. S. Clarke

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Management of large renal stones: laparoscopic pyelolithotomy versus percutaneous nephrolithotomy

    Management of large renal stones: laparoscopic pyelolithotomy versus percutaneous nephrolithotomy 由 Yunjin Bai, Yin Tang, Lan Deng, Xiaoming Wang, Yubo Yang, Jia Wang, Ping Han

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Work stress among Chinese nurses to support Wuhan in fighting against COVID‐19 epidemic

    Work stress among Chinese nurses to support Wuhan in fighting against COVID‐19 epidemic 由 Yuanyuan Mo, Lan Deng, Liyan Zhang, Qiuyan Lang, Chunyan Liao, Nannan Wang, Mingqin Qin, Huiqiao Huang

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    The Application of Biomaterials in Spinal Cord Injury

    The Application of Biomaterials in Spinal Cord Injury 由 Feng Chi, Lan Deng, Yuan-Yuan Yong, Jianming Wu, Dalian Qin, Lu Yu, Xiaogang Zhou, Anguo Wu

    出版 2023
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition

    Bispecific antibody simultaneously targeting PD1 and HER2 inhibits tumor growth via direct tumor cell killing in combination with PD1/PDL1 blockade and HER2 inhibition 由 Changling Gu, Haixia Zhu, Lan Deng, Xiaoqing Meng, Kai Li, Wei Xu, Le Zhao, Yueqin Liu, Zhenping Zhu, Haomin Huang

    出版 2021
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action

    A new anti-HER2 antibody that enhances the anti-tumor efficacy of trastuzumab and pertuzumab with a distinct mechanism of action 由 Xuesai Zhang, Jianhe Chen, Zhibing Weng, Qingrou Li, Le Zhao, Ning Yu, Lan Deng, Wei Xu, Yan Yang, Zhenping Zhu, Haomin Huang

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Neutrophil percentage to albumin ratio is associated with stroke-associated pneumonia and poor outcome in patients with spontaneous intracerebral hemorrhage

    Neutrophil percentage to albumin ratio is associated with stroke-associated pneumonia and poor outcome in patients with spontaneous intracerebral hemorrhage 由 Xin‐Ni Lv, Yiqing Shen, Zuo‐Qiao Li, Lan Deng, Zijie Wang, Jing Cheng, Xiao Hu, Ming‐Jun Pu, Wen‐Song Yang, Peng Xie, Qi Li

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation

    Effect of sorafenib on the outcomes of patients with FLT3-ITD acute myeloid leukemia undergoing allogeneic hematopoietic stem cell transplantation 由 Li Xuan, Yu Wang, Fen Huang, Erlie Jiang, Lan Deng, Bingyi Wu, Zhiping Fan, Xinquan Liang, Na Xu, Jieyu Ye, Ren Lin, Changxin Yin, Yuanyuan Zhang, Jing Sun, Mingzhe Han, Xiao‐Jun Huang, Qifa Liu

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

    Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label... 由 Ke Zhao, Ren Lin, Zhiping Fan, Xiaoyong Chen, Yu Wang, Fen Huang, Na Xu, Xi Zhang, Xin Zhang, Li Xuan, Shunqing Wang, Dongjun Lin, Lan Deng, Danian Nie, Jianyu Weng, Yonghua Li, Xiaohui Zhang, Yuhua Li, Andy Peng Xiang, Qifa Liu

    出版 2022
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas

    Phase I Trial of Fourth-Generation Anti-CD19 Chimeric Antigen Receptor T Cells Against Relapsed or Refractory B Cell Non-Hodgkin Lymphomas 由 Xuan Zhou, Sanfang Tu, Chunsheng Wang, Rui Huang, Lan Deng, Chaoyang Song, Chunyan Yue, Yanjie He, Jilong Yang, Liang Zhao, Anqin Wu, Meifang Li, Weijun Zhou, Jingwen Du, Zhenling Guo, LI Yong-qian, Cheng Jiao, Yuchen Liu, Lung‐Ji Chang, Yuhua Li

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1

    Deciphering a reliable synergistic bispecific strategy of rescuing antibodies for SARS-CoV-2 escape variants, including BA.2.86, EG.5.1, and JN.1 由 Zhou Tong, Jianyu Tong, Wenwen Lei, Yufeng Xie, Yingzi Cui, Guowen Jia, Shihua Li, Zezhong Zhang, Zhimin Cheng, Xiao Xing, Haiyun Ma, Lan Deng, Rong Zhang, Xin Zhao, Kefang Liu, Qihui Wang, Jianxun Qi, Haomin Huang, Rui Song, Zhaoming Su, Guizhen Wu, Jing Lou, George F. Gao

    出版 2024
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial

    Venetoclax Combined with Azacitidine and Homoharringtonine in Relapsed/Refractory AML: A Multicenter, Phase 2 Trial 由 Hua Jin, Yu Zhang, Sijian Yu, Xin Du, Na Xu, Ruoyang Shao, Dongjun Lin, Yanqiu Chen, Jie Xiao, Zhiqiang Sun, Lan Deng, Xinquan Liang, Hongyu Zhang, Ziwen Guo, Min Dai, Pengcheng Shi, Fen Huang, Zhiping Fan, Zhao Yin, Li Xuan, Ren Lin, Xuejie Jiang, Guopan Yu, Qifa Liu

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial

    Busulfan Plus Cyclophosphamide Versus Total Body Irradiation Plus Cyclophosphamide for Adults Acute B Lymphoblastic Leukemia: An Open-Label, Multicenter, Phase III Trial 由 Haiyan Zhang, Zhiping Fan, Fen Huang, Lijie Han, Yajing Xu, Na Xu, Lan Deng, Shunqing Wang, Dongjun Lin, Xiaodan Luo, Qing Zhang, Xiaodan Liu, Xudong Li, Xinquan Liang, Shuangfeng Xie, Hong Qu, Sijian Yu, Hongsheng Zhou, Pengcheng Shi, Li Xuan, Ren Lin, Hui Liu, Hua Jin, Jing Sun, Qifa Liu

    出版 2022
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: